ArticleJournal of advanced veterinary and animal research2024
Green synthesis of zinc oxide nanoparticles utilizing extract from
Article in Journal of advanced veterinary and animal research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Biosynthesis of ecofriendly antibacterial nanoparticles with healing effects in a murine diabetic skin infection model.Scientific reports · 2026Article
- Green-synthesized zinc oxide nanoparticles fromVeterinary world · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to synthesize eco-friendly zinc oxide nanoparticles (ZnO NPs) by utilizing Materials and Methods: An evaluation was conducted to analyze ZnO NPs using an aqueous extract of Results: The PSA and SEM indicated that the ZnO NPs had an average particle size ranging from 641.97 nm to 915.94 nm. Furthermore, the nanoparticles were found in both individual nanoforms and agglomerated forms. The EDX study indicated that the primary constituents of the ZnO NPs were zinc and oxygen. Additionally, the XRD examination demonstrated a distinct peak at 2θ = 36.25°, confirming the presence of a crystalline ZnO structure. The crystal size was determined to be between 40.98 nm and 46.92 nm. An FTIR spectroscopic study verified the existence of ZnO vibrations at distinct wavelengths as well as the absorption peak of the -OH functional group within the range of 3330.58 nm-3415.04 nm. Conclusion: The findings suggest that ZnO NPs produced utilizing the aqueous extract of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.